Status:
COMPLETED
TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin
Lead Sponsor:
Cairo University
Conditions:
Rectus Sheath Hematoma
Cesarean Section
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
The aim of this randomized controlled study is to demonstrate the effect of Local application of TXA impregnated in a gelatin sponge in reducing Rectus sheath hematoma formation in patients treated wi...
Detailed Description
The study will include (63) pregnant women attending for cesarean delivery who will receive anticoagulation (warfarin) postnatally. Patients included in this study will be subjected to: \- Informed ...
Eligibility Criteria
Inclusion
- o Pregnant women attending for elective CS.
- Women on antenatal anticoagulation ( LMWH , UFH , Fondaparinux ) for conditions such as : Prosthetic Valve , DVT , Pulmonary embolism , Dural sinus thrombosis , AF.
- Pregnant Women with indication for postnatal warfarin anticoagulation( Prosthetic Valve , DVT , Dural Sinus Thrombosis , AF , Pulmonary embolism )
- Age between 20-40 years.
- Pregnancies between 37 and 39 weeks
- BMI between (18.5 - 30.0)
Exclusion
- o Pregnancy with risk of obstetric hemorrhage such as abnormally invasive placenta, placenta previa, placental abruption.
- Women with Renal and Hepatic failure
- Women with bleeding diathesis for reasons other than warfarin anticoagulation therapy
- Women with known allergy to Tranexamic acid
- Anemia Hb below 8g/dl
Key Trial Info
Start Date :
July 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT05439694
Start Date
July 3 2022
End Date
February 1 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt